Comparison of Sugammadex With Neostigmine as Reversal Agents for Rocuronium at Reappearance of T2 (Study P06101)

NCT01050543 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuromuscular Blockade

Interventions

DRUG: sugammadex
DRUG: neostigmine

Sponsor

Merck Sharp & Dohme LLC